Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - AMAG PHARMACEUTICALS, INC. | q12020rex992.htm |
| EX-99.1 - EX-99.1 - AMAG PHARMACEUTICALS, INC. | q12020ex991.htm |
| 8-K - 8-K - AMAG PHARMACEUTICALS, INC. | amag-20200508.htm |
Exhibit 16.1
May 11, 2020
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by AMAG Pharmaceuticals, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K, as part of the Form 8-K of AMAG Pharmaceuticals, Inc. dated May 8, 2020. We agree with the statements concerning our Firm in such Form 8-K.
Very truly yours,
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
Attachment